Combination Therapy Involving Antibodies Against Claudin 18.2 For

Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer

Abstract: The present invention provides a combination therapy for treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.

Patent Information

Application #

Filing Date

22 September 2023

Publication Number

40/2023

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

ASTELLAS PHARMA INC.

5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411

Inventors

1. BHATTACHARYA, Pranob P.

Lake Forest, IL 60045

2. WENG, Jane

c/o Astellas Pharma Inc., 5-1 , Nihonbashi-Honcho 2-chome Chuo-ku, Tokyo 103-8411

3. KINUGASA, Fumitaka

c/o Astellas Pharma Inc., 5-1 , Nihonbashi-Honcho 2-chome Chuo-ku, Tokyo 103-8411

Specification

Documents

Application Documents

#	Name	Date
1	202347063645-STATEMENT OF UNDERTAKING (FORM 3) [22-09-2023(online)].pdf	2023-09-22
2	202347063645-Sequence Listing in txt [22-09-2023(online)].txt	2023-09-22
3	202347063645-Sequence Listing in PDF [22-09-2023(online)].pdf	2023-09-22
4	202347063645-PROOF OF RIGHT [22-09-2023(online)].pdf	2023-09-22
5	202347063645-PRIORITY DOCUMENTS [22-09-2023(online)].pdf	2023-09-22
6	202347063645-FORM 1 [22-09-2023(online)].pdf	2023-09-22
7	202347063645-DRAWINGS [22-09-2023(online)].pdf	2023-09-22
8	202347063645-DECLARATION OF INVENTORSHIP (FORM 5) [22-09-2023(online)].pdf	2023-09-22
9	202347063645-COMPLETE SPECIFICATION [22-09-2023(online)].pdf	2023-09-22
10	202347063645-FORM-26 [29-12-2023(online)].pdf	2023-12-29
11	202347063645-FORM 3 [14-03-2024(online)].pdf	2024-03-14
12	202347063645-FORM 18 [21-03-2025(online)].pdf	2025-03-21